FDA Inspection
Hospira Zagreb d.o.o.Hospira Zagreb d.o.o. – FDA Inspection, Feb 20, 2018
Record Details
This FDA Inspection record concerns Hospira Zagreb d.o.o., with an inspection on February 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Marion Michaelis (Investigator)
- Maxwell L. Van Tassell (Issuing Officer)
- Reyes Candau-Chacon (Issuing Officer)
View Company Profile
ID · dad8f345-4f2f-46ea-9de9-fe6cb5716d0f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1051780
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hospira Zagreb d.o.o.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hospira Zagreb d.o.o.
- FDA Inspection 1225278 - 2023-11-07
- FDA Inspection 1226933 - 2021-12-16
- FDA Inspection 1123692 - 2019-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.